Michael Kelly
Chief Executive Officer at NERVGEN PHARMA CORP.
Net worth: 889 226 $ as of 29/04/2024
Michael Kelly active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ARS PHARMACEUTICALS, INC. | Director/Board Member | 30/04/2019 | - |
| Independent Dir/Board Member | 30/04/2019 | - | |
| NERVGEN PHARMA CORP. | Director/Board Member | 09/04/2023 | - |
| Chief Executive Officer | 09/04/2023 | - | |
| President | 09/04/2023 | - | |
ARS Subsidiary, Inc.
 ARS Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology ARS Pharmaceuticals, Inc. develops epinephrine nasal sprays for treatment of severe allergic reactions to food, medication, and insect bites. The company was founded by Richard E. Lowenthal, Sarina Tanimoto and Robert Bell and is headquartered in San Diego, CA. | Director/Board Member | 30/04/2019 | - |
Career history of Michael Kelly
Former positions of Michael Kelly
| Companies | Position | Start | End |
|---|---|---|---|
Emergent Devices, Inc.
 Emergent Devices, Inc. Pharmaceuticals: MajorHealth Technology Part of Emergent BioSolutions, Inc., Emergent Devices, Inc. is a pharmaceutical company that manufactures pharmaceutical products. The company is based in Plymouth Meeting, PA. | Chief Operating Officer | 29/02/2016 | 31/05/2019 |
Covis Pharmaceuticals, Inc.
 Covis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Covis Pharmaceuticals, Inc. specializes and distributes pharmaceutical products. It is a specialty pharmaceutical distributor dedicated to improving the lives of people with life-threatening conditions and chronic illnesses. The company was founded on November 2, 2011 and is headquartered in Chesterbrook, PA. | Director/Board Member | 30/11/2013 | 29/02/2016 |
| Chief Executive Officer | 30/11/2013 | 29/02/2016 | |
| President | 30/11/2013 | 29/02/2016 | |
Azur Pharma Ltd.
 Azur Pharma Ltd. Pharmaceuticals: MajorHealth Technology Azur Pharma Ltd. manufactures pharmaceutical products. It offers branded generic prescription drugs, antibiotics and medicines in multiple therapeutic areas. The company was founded in May, 2005 and is headquartered in Dublin, IE | Corporate Officer/Principal | - | 26/01/2012 |
Jazz Pharmaceuticals Commercial Corp.
 Jazz Pharmaceuticals Commercial Corp. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals Commercial Corp. provides pharmaceutical services. It engages in identifying, developing, and commercializing products in the areas of CNS, women's health, and urology. The company was founded in 2005 and is headquartered in Philadelphia, PA. | Corporate Officer/Principal | 06/12/2010 | 31/12/2011 |
Guilford Pharmaceuticals, Inc.
 Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the research, development and commercialization of proprietary drugs that target the hospital and neurology markets. Presently, Guilford markets two commercial products, GLIADEL(R) Wafer, for the treatment of brain cancer, and AGGRASTAT(R) Injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome (ACS). Guilford's product pipeline includes a novel anesthetic, AQUAVAN(R) Injection, and drugs for treating Parkinson's disease and peripheral nerve injury | Chief Operating Officer | - | 02/10/2005 |
| Viropharma, Inc. | Sales & Marketing | - | - |
| ░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░ ░ ░░░░░░░░░ | ░░░░░░░░░░ | - |
Training of Michael Kelly
| Rider University | Masters Business Admin |
| The College of New Jersey | Undergraduate Degree |
Statistics
International
| United States | 10 |
| Ireland | 3 |
| Canada | 2 |
Operational
| Director/Board Member | 4 |
| Corporate Officer/Principal | 3 |
| Sales & Marketing | 2 |
Sectoral
| Health Technology | 10 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| JAZZ PHARMACEUTICALS PLC | Health Technology |
| ARS PHARMACEUTICALS, INC. | Health Technology |
| NERVGEN PHARMA CORP. | Health Technology |
| Private companies | 7 |
|---|---|
Jazz Pharmaceuticals Commercial Corp.
Jazz Pharmaceuticals Commercial Corp. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals Commercial Corp. provides pharmaceutical services. It engages in identifying, developing, and commercializing products in the areas of CNS, women's health, and urology. The company was founded in 2005 and is headquartered in Philadelphia, PA. | Health Technology |
ARS Subsidiary, Inc.
ARS Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology ARS Pharmaceuticals, Inc. develops epinephrine nasal sprays for treatment of severe allergic reactions to food, medication, and insect bites. The company was founded by Richard E. Lowenthal, Sarina Tanimoto and Robert Bell and is headquartered in San Diego, CA. | Health Technology |
Covis Pharmaceuticals, Inc.
Covis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Covis Pharmaceuticals, Inc. specializes and distributes pharmaceutical products. It is a specialty pharmaceutical distributor dedicated to improving the lives of people with life-threatening conditions and chronic illnesses. The company was founded on November 2, 2011 and is headquartered in Chesterbrook, PA. | Health Technology |
Emergent Devices, Inc.
Emergent Devices, Inc. Pharmaceuticals: MajorHealth Technology Part of Emergent BioSolutions, Inc., Emergent Devices, Inc. is a pharmaceutical company that manufactures pharmaceutical products. The company is based in Plymouth Meeting, PA. | Health Technology |
Azur Pharma Ltd.
Azur Pharma Ltd. Pharmaceuticals: MajorHealth Technology Azur Pharma Ltd. manufactures pharmaceutical products. It offers branded generic prescription drugs, antibiotics and medicines in multiple therapeutic areas. The company was founded in May, 2005 and is headquartered in Dublin, IE | Health Technology |
Guilford Pharmaceuticals, Inc.
Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the research, development and commercialization of proprietary drugs that target the hospital and neurology markets. Presently, Guilford markets two commercial products, GLIADEL(R) Wafer, for the treatment of brain cancer, and AGGRASTAT(R) Injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome (ACS). Guilford's product pipeline includes a novel anesthetic, AQUAVAN(R) Injection, and drugs for treating Parkinson's disease and peripheral nerve injury | Health Technology |
| Viropharma, Inc. |
- Stock Market
- Insiders
- Michael Kelly
- Experience
